|
G-P maintains its top position for the fourth consecutive year, recognized for compliance depth and agentic AI innovation
BOSTON, April 28, 2026 /PRNewswire/ -- G-P (Globalization Partners), recognized as the undisputed leader in global employment by industry analysts, today announced it has been named the Employer of Record (EOR) industry leader in The IEC Group Global EOR Study 2026 and IEC Dynamic Map™ Quadrant. This marks the fourth consecutive year G-P has secured the #1 position, distinguished by its strength in delivering scalable, agentic AI-enabled global employment and compliance solutions across 180+ countries.
"G-P is the benchmark in the global EOR market, combining strong compliance depth and enterprise-grade platform maturity, " said Luis Praxmarer, CEO & practitioner at The IEC Group. "With G-P Contractor and G-P Gia, the company further reinforces its position as a leading partner for complex international workforce expansion."
The IEC Group's Global EOR Study assesses the key providers of international EOR services delivering both advanced and fully managed solutions from their own resources or with partner ecosystem assistance. G-P earned the top position among the 30 leading companies in the industry, specifically cited for its platform quality and its ability to de-risk international expansion for large-scale enterprises.
"Holding the top spot for four years isn't a victory lap, it is a testament to G-P's role as the operating system for a global workforce," said Nat Natarajan, Chief Operating Officer, G-P. "By embedding agentic AI into our core infrastructure, we aren't just facilitating hiring, we are ensuring compliance and intelligence are native to every workflow, allowing our customers to move at the speed of the market."
Read the report and learn more about G-P's industry leadership here.
About G-P
G-P (Globalization Partners) is the recognized leader in global employment, ranked No. 1 in every industry analyst report. G-P's global employment platform delivers everything companies of all sizes need to manage the full employee lifecycle with its trusted Global HR Agent, G-P Gia, and AI-powered Employer of Record (EOR) and Contractor products. G-P supports teams in 180+ countries with more than a decade of global employment experience, the largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.
G-P: Global Made Possible™
To learn more, please visit: g-p.com or connect with us via LinkedIn, X, Facebook or check out our Blog.
G-P maintains its top position for the fourth consecutive year, recognized for compliance depth and agentic AI innovation
BOSTON, April 28, 2026 /PRNewswire/ -- G-P (Globalization Partners), recognized as the undisputed leader in global employment by industry analysts, today announced it has been named the Employer of Record (EOR) industry leader in The IEC Group Global EOR Study 2026 and IEC Dynamic Map™ Quadrant. This marks the fourth consecutive year G-P has secured the #1 position, distinguished by its strength in delivering scalable, agentic AI-enabled global employment and compliance solutions across 180+ countries.
"G-P is the benchmark in the global EOR market, combining strong compliance depth and enterprise-grade platform maturity, " said Luis Praxmarer, CEO & practitioner at The IEC Group. "With G-P Contractor and G-P Gia, the company further reinforces its position as a leading partner for complex international workforce expansion."
The IEC Group's Global EOR Study assesses the key providers of international EOR services delivering both advanced and fully managed solutions from their own resources or with partner ecosystem assistance. G-P earned the top position among the 30 leading companies in the industry, specifically cited for its platform quality and its ability to de-risk international expansion for large-scale enterprises.
"Holding the top spot for four years isn't a victory lap, it is a testament to G-P's role as the operating system for a global workforce," said Nat Natarajan, Chief Operating Officer, G-P. "By embedding agentic AI into our core infrastructure, we aren't just facilitating hiring, we are ensuring compliance and intelligence are native to every workflow, allowing our customers to move at the speed of the market."
Read the report and learn more about G-P's industry leadership here.
About G-P
G-P (Globalization Partners) is the recognized leader in global employment, ranked No. 1 in every industry analyst report. G-P's global employment platform delivers everything companies of all sizes need to manage the full employee lifecycle with its trusted Global HR Agent, G-P Gia, and AI-powered Employer of Record (EOR) and Contractor products. G-P supports teams in 180+ countries with more than a decade of global employment experience, the largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.
G-P: Global Made Possible™
To learn more, please visit: g-p.com or connect with us via LinkedIn, X, Facebook or check out our Blog.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
G-P Secures #1 Leader Ranking in 2026 IEC Group Global EOR Study
SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards.
CiteAb accelerates scientific research by providing a search engine and data services, and its awards leverage high-quality citation data from publications to impartially recognize excellence in the reagent industry.
The award is based on analysis of the CiteAb protein database, which tracks over 300 suppliers. ACROBiosystems was recognized for achieving the second-highest year-over-year growth in protein citations from cancer-related publications, meeting the required citation threshold.
"We are pleased to recognise ACROBiosystems as Highly Commended in the Protein Supplier to Watch in Cancer Research Award." — Official citation from CiteAb Awards.
At the American Association for Cancer Research (AACR) event, ACROBiosystems' Dr. Yu Sun, VP of Product Development received the award and stated, "I am truly delighted that our proteins have earned top citations from scientists - this represents recognition and trust from the industry."
"ACROBiosystems' portfolio extends beyond proteins to include antibodies, kits, and services. These are applied not only to oncology but also to autoimmune diseases, cardiovascular diseases, infectious diseases, neurology, and other therapeutic areas. They support R&D and production processes including drug screening/optimization, preclinical research, clinical trials, CMC development, and diagnostic reagent development."
"ACROBiosystems upholds the core brand value of 'Reliable Quality, Integrated Innovation, Considerate Service', and is committed to providing innovative products and solutions to overcome challenges throughout the entire biopharmaceutical process, from R&D and production to clinical application."
ACROBiosystems Group's strategic commitment to quality is upheld through a stringent quality management system. The Group obtained ISO 9001 certification in 2016, established a GMP system in 2021, and achieved dual ISO 9001 and GMP certification at its Suzhou production site in 2024. Its specialized quality team monitors global regulations and industry trends, enabling agile adaptation of management systems to diverse product profiles, customer applications, and evolving compliance requirements—ensuring development and production align with both client specifications and regulatory standards.
The company's "Considerate Service" is reflected in several key dimensions: expedited logistics that ensure industry-leading delivery; 24-hour technical support for immediate issue resolution; a comprehensive resource repository providing insights and protocols; and personalized client attention through dedicated service teams.
Similarly, "Integrated Innovation" is demonstrated through multiple facets: alignment with emerging therapeutic modalities, focus on pivotal disease areas, advancement of technology platforms enhanced by AI, and active collaboration within global innovation ecosystems.
About ACROBiosystems Group
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company spans across the globe and maintains offices, R&D centers, and production bases in more than 15 different cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world's top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.
Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and their clinical applications, and contributes to global health.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
